In murine allogeneic bone marrow transplantation, HGF ameliorated acute graft-versus-host disease (aGVHD) through the reduction of IL12 serum levels and suppression of target organ IFNγ and TNFa mRNA26. The gene discussed is TNF; the disease is acute graft versus host disease.